Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Effect of iron/folic Acid supplementation on the outcome of malaria episodes treated with sulfadoxine-pyrimethamine.

Sazawal S, Black RE, Kabole I, Dutta A, Dhingra U, Ramsan M.

Malar Res Treat. 2014;2014:625905. doi: 10.1155/2014/625905.

2.

Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial.

Sazawal S, Black RE, Ramsan M, Chwaya HM, Stoltzfus RJ, Dutta A, Dhingra U, Kabole I, Deb S, Othman MK, Kabole FM.

Lancet. 2006 Jan 14;367(9505):133-43. Erratum in: Lancet. 2006 Jan 28;367(9507):302.

PMID:
16413877
3.

Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.

Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P, Greenwood B, Walraven G.

Am J Trop Med Hyg. 2006 Jun;74(6):960-4.

4.

Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria.

van Hensbroek MB, Morris-Jones S, Meisner S, Jaffar S, Bayo L, Dackour R, Phillips C, Greenwood BM.

Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):672-6.

PMID:
8594693
5.

Randomized, controlled trial of daily iron supplementation and intermittent sulfadoxine-pyrimethamine for the treatment of mild childhood anemia in western Kenya.

Desai MR, Mei JV, Kariuki SK, Wannemuehler KA, Phillips-Howard PA, Nahlen BL, Kager PA, Vulule JM, ter Kuile FO.

J Infect Dis. 2003 Feb 15;187(4):658-66.

6.

Randomized intervention study comparing several regimens for the treatment of moderate anemia among refugee children in Kigoma Region, Tanzania.

Tomashek KM, Woodruff BA, Gotway CA, Bloland P, Mbaruku G.

Am J Trop Med Hyg. 2001 Mar-Apr;64(3-4):164-71.

7.

Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.

Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG.

Malar J. 2008 Jun 11;7:106. doi: 10.1186/1475-2875-7-106.

8.

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate.

Shekalaghe S, Drakeley C, Gosling R, Ndaro A, van Meegeren M, Enevold A, Alifrangis M, Mosha F, Sauerwein R, Bousema T.

PLoS One. 2007 Oct 10;2(10):e1023.

9.

Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana.

Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, Mensah N, Jaffar S, Baiden R, Hodgson A, Binka F, Greenwood B.

BMJ. 2005 Oct 1;331(7519):727-33.

10.

A randomised, double-blind, placebo-controlled trial of atovaquone-proguanil vs. sulphadoxine-pyrimethamine in the treatment of malarial anaemia in Zambian children.

Mulenga M, Malunga F, Bennett S, Thuma PE, Shulman C, Fielding K, Alloueche A, Greenwood BM.

Trop Med Int Health. 2006 Nov;11(11):1643-52.

11.
13.

The effect of oral iron therapy during treatment for Plasmodium falciparum malaria with sulphadoxine-pyrimethamine on Malawian children under 5 years of age.

Nwanyanwu OC, Ziba C, Kazembe PN, Gamadzi G, Gandwe J, Redd SC.

Ann Trop Med Parasitol. 1996 Dec;90(6):589-95.

PMID:
9039270
14.

Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial.

Obonyo CO, Ochieng F, Taylor WR, Ochola SA, Mugitu K, Olliaro P, ter Kuile F, Oloo AJ.

Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):585-91.

PMID:
15307433
15.

Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation.

Carter JY, Loolpapit MP, Lema OE, Tome JL, Nagelkerke NJ, Watkins WM.

Am J Trop Med Hyg. 2005 Jul;73(1):166-70.

16.

Developmental effects of micronutrient supplementation and malaria in Zanzibari children.

Olney DK, Kariger PK, Stoltzfus RJ, Khalfan SS, Ali NS, Tielsch JM, Sazawal S, Black R, Allen LH, Pollitt E.

Early Hum Dev. 2013 Sep;89(9):667-74. doi: 10.1016/j.earlhumdev.2013.04.013.

PMID:
23725789
17.

Sickle-cell disease and malaria: evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients-a randomized placebo-controlled trial.

Diop S, Soudré F, Seck M, Guèye YB, Diéye TN, Fall AO, Sall A, Thiam D, Diakhaté L.

Ann Hematol. 2011 Jan;90(1):23-7. doi: 10.1007/s00277-010-1040-z.

PMID:
20694469
18.

Relation between the response to iron supplementation and sickle cell hemoglobin phenotype in preschool children in western Kenya.

Terlouw DJ, Desai MR, Wannemuehler KA, Kariuki SK, Pfeiffer CM, Kager PA, Shi YP, Ter Kuile FO.

Am J Clin Nutr. 2004 Mar;79(3):466-72.

19.

A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria.

Mockenhaupt FP, Ehrhardt S, Dzisi SY, Teun Bousema J, Wassilew N, Schreiber J, Anemana SD, Cramer JP, Otchwemah RN, Sauerwein RW, Eggelte TA, Bienzle U.

Trop Med Int Health. 2005 Jun;10(6):512-20.

20.
Items per page

Supplemental Content

Support Center